The importance of the VEGF-load in platelets in cancer patients [3]

Annals of Oncology

Volumn 13, Issue 10, 2002, Pages 1689-1690

  Salgado, R ^a   Benoy, I ^a   van Marck, E ^a   Vermeulen, P ^a   Dirix, L ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; INTERLEUKIN 6; METHOTREXATE; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER GROWTH; CANCER PATIENT; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; LETTER; METASTASIS; PRIORITY JOURNAL; THROMBOCYTE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD PLATELETS; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-6; LYMPHOKINES; PLATELET COUNT; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036809719     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf320     Document Type: Letter

References (6)

1. Colleoni M, Rocca A, Sandri MT et al. Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. Ann Oncol 2002; 13: 73-80.
2. Salgado R, Vermeulen PB, Van Marck E et al. Correspondence re: M. L. George et al., Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin. Cancer Res., 6: 3147-3152, 2000. Clin Cancer Res 2001; 7: 1481-1483.
3. Benoy I, Salgado R, Colpaert C et al. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clin Breast Cancer 2002; 2: 311-315.
4. Salgado R, Vermeulen PB, Benoy I et al. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br J Cancer 1999; 80: 892-897.
5. Salgado R, Benoy I, Weytjens R et al. Serum vascular endothelial growth factor load and interleukin-6 in cancer patients-reply. Br J Cancer 2000; 82: 1896.
6. Dirix LY, Salgado R, Weytjens R et al. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer 2002; 86: 389-395.